Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Encapsulated cell therapy - Rogosin Institute/Metromedia Bio-Science

Next Previous
Search
Drug Profile

Encapsulated cell therapy - Rogosin Institute/Metromedia Bio-Science

Alternative Names: Cancer cell-containing agarose-agarose macrobeads; Cancer inhibitor macrobead - Metromedia Bio-Science; Macrobead biological anti-tumour therapy; Macrobead cancer therapy - Rogosin Institute; Macrobeads; Mouse renal adenocarcinoma cell-containing agarose-agarose macrobeads; Mouse renal carcinoma (RENCA) macrobeads; RENCA macrobeads

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rogosin Institute
  • Class Antineoplastics; Cell therapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Colorectal cancer; Pancreatic cancer; Prostate cancer

Most Recent Events

  • 16 Aug 2015 Encapsulated cell therapy is still in phase II trials for Pancreatic cancer (Refractory metastatic disease) in the USA
  • 16 Aug 2015 Encapsulated cell therapy is still in phase II trials for Prostate cancer (Refractory metastatic disease) in the USA
  • 16 Aug 2015 Encapsulated cell therapy is still in phase II trials for Colorectal cancer (Refractory metastatic disease) in the USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top